Bronchoconstriction with inhaled ATP in healthy volunteers
European Respiratory Journal · 2024
DOI: 10.1183/13993003.00880-2024 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Respiratory Journal, 2024. Verfasst von Jenny King und 4 weiteren Autor:innen. Beteiligte Einrichtung: The University of Manchester, Manchester, UK jenny.king@manchester.ac.uk. Hauptthemen laut MEDLINE: Bronchoconstriction, Adenosine Triphosphate, Healthy Volunteers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
P2X3 receptors are found on sensory nerves and are activated by ATP. The recent discovery that P2X3 antagonism is effective in treating patients with refractory chronic cough [1–4], has prompted recent studies of the effects of inhaled ATP, but few data exist pertaining to its safety and tolerability. We recently studied inhaled ATP in healthy volunteers, identifying adverse effects not previously reported. Footnotes This manuscript has recently been accepted for publication in the European Respiratory Journal . It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article. Conflict of Interest: A. Versi has nothing to disclose. Conflict of Interest: J. King reports support for the present study from Wellcome, and grants from Wellcome. Conflict of Interest: P. Marsden reports grants from Merck and NW Lung Centre Charity, and payment or honoraria for lectures, presentations, manuscript writing or educational events from Olympus. Conflict of Interest: R. Dockry has nothing to disclose. Conflict of Interest: S. Fowler has nothing to disclose. Conflict of Interest: J. Smith reports support for the present study from Wellcome, grants from Wellcome and Merck, royalties or licences from Vitalograph, consultancy fees from Merck, Bellus Health, Bayer, Shionogi, Algernon, AstraZeneca, Boehringer Ingelheim and Chiesi, payment or honoraria for lectures, presentations, manuscript writing or educational events from Merck, a patent on cough algorithm licenced by Manchester University NHS Foundation Trust to Vitalograph, and receipt of equipment, materials, drugs, medical writing, gifts or other services from Vitalograph.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The University of Manchester, Manchester, UK jenny.king@manchester.ac.uk.
- Manchester University NHS Foundation Trust, Manchester, UK.
- The University of Manchester, Manchester, UK.
ORCID-Profile: Jenny King, Rachel Dockry, Stephen Fowler, Jaclyn Smith
Förderung
- Wellcome Trust
Zitieren
APA
King, J., Dockry, R., Marsden, P., Fowler, S., & Smith, J. (2024). Bronchoconstriction with inhaled ATP in healthy volunteers. European Respiratory Journal. https://doi.org/10.1183/13993003.00880-2024
Vancouver
King J, Dockry R, Marsden P, Fowler S, Smith J. Bronchoconstriction with inhaled ATP in healthy volunteers. European Respiratory Journal. 2024. doi:10.1183/13993003.00880-2024
BibTeX
@article{King2024,
author = {King, Jenny and Dockry, Rachel and Marsden, Paul and Fowler, Stephen and Smith, Jaclyn},
title = {Bronchoconstriction with inhaled ATP in healthy volunteers},
journal = {European Respiratory Journal},
year = {2024},
doi = {10.1183/13993003.00880-2024}
}
EUVIMED